Highlights: New US Department of Defense award to develop two new oral therapeutics targeting Campylobacter and ShigellaUniformed Services University P2TD clinical study update MELBOURNE, Australia, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback